generic glp-1 drugs There's still no Ozempic, but a lower-priced daily injected is coming Surge of generic weight-loss drugs
Description
"Exenatide once a week versus placebo as a potential disease-modifying treatment for people with Parkinson's disease in the UK: a phase 3, multicentre, double-blind, parallel-group, randomised, placebo-controlled trial"
What Actually Supports People Using GLP-1 Medications GLP-1 medications can meaningfully change appetite, meal size, and digestion
doi:10.2337/db11-0979 Melson E, Ashraf U, Papamargaritis D, Davies MJ
One is the ability of the excipients to inhibit the activity of proteases in the intestine
PLoS ONE 8 , e71108
4952 The proportion of subjects withdrawing from trials due to gastrointestinal symptoms is about 5%
